FGFR3 and neoplasm: In order to more directly assess the role oncogenic FGFR3 was playing in subtype-specific cells, we treated tumor-bearing UPFL mice with vehicle or erdafitinib, a small-molecule inhibitor of FGFR (n = 2 per group).